ADAT1 exclusively targets adenosine at position 37 in the anticodon loop of tRNA-Ala, a conserved modification across eukaryotes . Key findings include:
Mechanism: Hydrolytic deamination of A37, forming inosine, which may undergo further methylation to N1-methylinosine (m1I37) .
Substrate Requirements: Requires the full-length tRNA-Ala structure; isolated anticodon stem-loops are insufficient .
Specificity: Does not edit double-stranded RNA or pre-mRNA substrates of other ADAR proteins .
Efficiency: Higher activity on tRNA-Ala from humans and Bombyx mori compared to yeast .
Gene Structure: The ADAT1 gene spans ~30 kb, with nine exons in mice and humans .
Homology: 87.5% protein identity between human and mouse ADAT1 .
Evolution: Functional homologs exist in Drosophila melanogaster and yeast (Tad1p), though yeast lacks the 90-amino acid insert found in human ADAT1 .
ADAT1 is ubiquitously expressed, with transcript levels highest in the heart, brain, and pancreas . Northern blot analyses detect two transcripts (5.0 kb and 6.5 kb), likely due to extended 3'-untranslated regions .
Recombinant Protein: Available as a non-glycosylated, E. coli-derived product (ENZ-307) .
ELISA Kits: Detect native ADAT1 in biological samples (e.g., MBS7209441) .
Antibodies: Rabbit polyclonal antibodies (e.g., ab122662) validated for WB, IHC-P, and ICC/IF .
ADAT1 is linked to:
ADAT1 (Adenosine Deaminase tRNA-Specific 1) is a member of the ADAR (adenosine deaminase acting on RNA) family. Its primary function is the site-specific deamination of adenosine 37 to inosine in eukaryotic tRNA(Ala) . Unlike other ADAR family members that modify various RNA substrates, ADAT1 displays remarkable specificity for tRNA(Ala). This modification represents the first step of the unique A(37) to m(1)I(37) modification pathway in eukaryotic tRNA(Ala) .
The human ADAT1 protein consists of 502 amino acids with a molecular mass of approximately 57.7 kDa . It is expressed ubiquitously in human tissues and is encoded by a single gene . This enzyme is the functional homologue of the yeast protein Tad1p, indicating evolutionary conservation of this modification mechanism .
While ADAT1 belongs to the ADAR family, it has distinct substrate specificity compared to other family members:
This specialized function separates ADAT1 from its ADAR relatives, making it a unique enzyme within this family focused specifically on tRNA modification rather than broader RNA editing activities.
For optimal expression and purification of human ADAT1:
Expression Systems:
Escherichia coli has been successfully used as an expression system for producing recombinant human ADAT1 . The recombinant protein is typically expressed as a non-glycosylated polypeptide chain containing amino acids 1-502 .
Purification Methods:
The most effective purification approach involves:
Formulation and Storage:
The purified protein is typically formulated in a buffer containing:
Component | Concentration |
---|---|
ADAT1 protein | 0.1 mg/ml |
Tris buffer | 10 mM, pH 8.0 |
Triton X-100 | 0.1% |
Sodium azide | 0.002% |
For storage, the enzyme should be kept at 4°C if used within 2-4 weeks, or frozen at -20°C for longer periods . Adding a carrier protein (0.1% HSA or BSA) is recommended for long-term storage, and multiple freeze-thaw cycles should be avoided .
Several approaches can be used to assess ADAT1 activity:
Substrate Preparation:
Use purified tRNA(Ala) from either:
In vitro transcription of tRNA(Ala) genes
Isolation from cellular sources (preferably higher eukaryotes for optimal activity)
Activity Assays:
Direct deamination detection: Monitor the conversion of adenosine to inosine at position 37 in tRNA(Ala) using techniques like thin-layer chromatography or mass spectrometry.
Comparative substrate analysis: Test ADAT1 activity on tRNA(Ala) from different species, as human ADAT1 shows higher efficiency with substrates from higher eukaryotes compared to lower eukaryotes .
Important Considerations:
The complete tRNA structure is necessary for ADAT1 activity; the anticodon stem-loop alone is not a functional substrate .
Negative controls should include testing activity on double-stranded RNA or pre-mRNAs that serve as substrates for ADAR1 or ADAR2, as ADAT1 should not modify these substrates .
ADAT1's specificity for tRNA(Ala) involves multiple recognition elements:
Structural requirements: Research demonstrates that the anticodon stem-loop of tRNA(Ala) alone is insufficient for recognition by ADAT1 . This indicates that tertiary structural elements or distant sequence motifs in the complete tRNA are essential for substrate recognition.
Species-dependent activity: Human ADAT1 deaminates tRNA(Ala) from higher eukaryotes efficiently but shows lower efficiency with substrates from lower eukaryotes . This suggests evolutionary adaptations in the enzyme-substrate recognition system.
Position-specific modification: ADAT1 specifically targets adenosine at position 37 in the anticodon loop, adjacent to the anticodon itself (positions 34-36) . This position is critical for maintaining proper tRNA function during translation.
Understanding this specificity requires investigation of both enzyme structural elements and tRNA features that facilitate this highly selective interaction. Mutagenesis studies of both the enzyme and substrate would help identify key recognition determinants.
The evolutionary significance of this modification is profound:
Phylogenetic conservation: The A37 to I37 modification in tRNA(Ala) is conserved from yeast to humans, indicating fundamental importance in cellular function . Both human and mouse ADAT1 are expressed from single-copy genes with similar organization .
Mouse-human homology: Mouse ADAT1 shares 81% nucleotide homology and 87.5% protein homology with human ADAT1, further demonstrating evolutionary conservation . The mouse enzyme is also active specifically and with high efficiency on human tRNA(Ala) in vitro .
Functional importance: The modification likely plays crucial roles in:
Stabilizing codon-anticodon interactions
Ensuring translational fidelity
Preventing frameshifting during protein synthesis
Multi-step modification: In eukaryotes, this represents the first step of a two-step modification, with I37 further modified to m(1)I(37) . This sequential modification pattern suggests coordinated evolution of RNA modification pathways.
For comparative genomic analysis of ADAT1:
Gene structure analysis:
Homology assessment:
Sequence alignment tools to compare ADAT1 across species
Phylogenetic analysis to understand evolutionary relationships
Structural prediction based on sequence conservation
Expression analysis:
Evaluating tissue-specific expression patterns
Identifying potential splice variants or isoforms
Promoter analysis:
To investigate ADAT1-tRNA structural interactions:
Mutagenesis approaches:
Systematic mutation of conserved residues in ADAT1 to identify those critical for tRNA binding and catalysis
Creation of chimeric constructs between ADAT1 and other ADAR family members to map substrate specificity domains
tRNA variant studies:
Generation of tRNA(Ala) variants with specific structural changes
Transplantation of tRNA(Ala) structural elements into non-substrate tRNAs to identify recognition determinants
Biophysical interaction analysis:
Surface plasmon resonance or isothermal titration calorimetry to measure binding kinetics
Crosslinking studies to identify contact points between ADAT1 and tRNA
Structural biology methods:
X-ray crystallography or cryo-EM of ADAT1-tRNA complexes
NMR studies of specific domains and their interaction with RNA elements
These approaches would generate a comprehensive understanding of the molecular basis for ADAT1's remarkable substrate specificity.
When facing contradictory results in ADAT1 studies:
Experimental variables assessment:
Substrate integrity verification:
Activity detection methods:
Employ multiple independent methods to verify results
Include appropriate positive and negative controls
Consider time-course experiments to capture reaction kinetics
Comparative analysis:
Test ADAT1 activity on tRNA(Ala) from different species as validation
Use relative activity measurements to normalize between experiments
For effective structure-function studies:
Domain organization analysis:
Evolutionary perspective:
Substrate specificity determinants:
Methodological integration:
Combine biochemical assays with structural studies
Correlate activity measurements with binding affinity determination
Consider computational modeling to guide experimental design
By systematically addressing these aspects, researchers can develop a comprehensive understanding of ADAT1 structure-function relationships, contributing to broader knowledge of RNA modification enzymes.
ADAT1 specifically deaminates adenosine at position 37 to inosine in eukaryotic tRNA, particularly in tRNA-Ala . This modification is essential for the proper functioning of tRNA, as inosine at position 37 is critical for maintaining the correct structure and function of the tRNA molecule . The enzyme’s activity involves site-specific adenosine modification, which is a key process in the pre-mRNA editing of nuclear transcripts .
The ADAT1 gene is located on chromosome 16q23.1 and consists of 9 exons . The gene is highly conserved across species, indicating its essential role in cellular processes. ADAT1 transcripts are found in various human tissues, with the highest expression levels observed in the heart, brain, and pancreas .
The ADAT1 protein shares significant sequence similarity with the yeast protein Tad1p, which also deaminates adenosine to inosine in tRNA . This evolutionary conservation suggests that the function of ADAT1 is critical across different organisms, highlighting its importance in maintaining the integrity of the genetic code during protein synthesis.
Mutations or dysregulation of the ADAT1 gene have been associated with several diseases, including prostate cancer and developmental and epileptic encephalopathy . Understanding the function and regulation of ADAT1 can provide insights into the molecular mechanisms underlying these conditions and potentially lead to the development of targeted therapies.
Recombinant human ADAT1 is used in various research applications to study RNA editing and its implications in health and disease. By using recombinant proteins, researchers can investigate the enzyme’s activity, substrate specificity, and potential inhibitors, which can contribute to the development of novel therapeutic strategies.